Ikarian Capital’s Olema Oncology OLMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.31M Hold
383,281
– – 0.33% 79
2026
Q2
$4.79M Sell
383,281
-215,000
-36% -$2.88M 0.52% 59
2026
Q1
$8.92M Sell
598,281
-160,373
-21% -$3.57M 0.72% 37
2025
Q4
$19M Buy
+758,654
New +$13.5M 1.48% 15
2025
Q2
– Sell
-191,994
Closed -$722K – 174
2025
Q1
$722K Buy
191,994
+100,000
+109% +$503K 0.09% 103
2024
Q4
$536K Sell
91,994
-6
-0% -$60 0.07% 130
2024
Q3
$1.1M Buy
+92,000
New +$1.18M 0.15% 93

Other funds holding OLMA

Ikarian Capital's OLMA Position: Q3 2026 in Review

Ikarian Capital held its Olema Oncology (OLMA) position steady in Q3 2026 at 383,281 shares worth $3.31M. The position accounts for 0.33% of the portfolio, ranked #79.

Ikarian Capital first reported a position in OLMA in Q3 2024 and has held it in 7 quarters since. The position peaked at $19M in Q4 2025. 179 funds tracked by Wall St. Rank hold OLMA as of Q3 2026.

  • Ikarian Capital held 383,281 shares of Olema Oncology worth $3.31M as of Q3 2026.
  • Ikarian Capital left its Olema Oncology share count unchanged in Q3 2026.
  • Olema Oncology made up 0.33% of Ikarian Capital's portfolio in Q3 2026, its #79 holding.
  • Ikarian Capital first reported a position in Olema Oncology in Q3 2024 and has held it in 7 quarters since.
  • Ikarian Capital's Olema Oncology position peaked at $19M in Q4 2025.
  • 179 funds tracked by Wall St. Rank held Olema Oncology as of Q3 2026.

Based on Ikarian Capital's 13F filing for Q3 2026, filed 16 Nov 2026.